Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2008			2007			2008			2007
Net Sales:
Aerospace & Electronics	$	159,716		$	158,999		$	484,095		$	467,563
Engineered Materials		58,174			80,719			213,884			256,180
Merchandising Systems		93,611			98,462			323,348			296,389
Fluid Handling		293,621			290,826			883,221			834,983
Controls		37,556			35,087			110,480			98,093
Total Net Sales	$	642,678		$	664,093		$	2,015,028		$	1,953,208
Operating Profit (Loss):
Aerospace & Electronics	$	10,896		$	23,090		$	45,378		$	68,481
Engineered Materials		4,410			15,742			24,164			49,713
Merchandising Systems		10,884			9,755			42,361			31,298
Fluid Handling		34,915			37,477			126,233			102,014
Controls		3,277			3,129			8,124			8,331
Corporate*		(9,764	)		(11,660	)		(30,022	)		(42,108	)
Asbestos Provision		—			(390,150	)		—			(390,150	)
Total Operating Profit (Loss)		54,618			(312,617	)		216,238			(172,421	)
Interest Income		3,212			1,535			8,379			3,837
Interest Expense		(6,053	)		(6,845	)		(19,236	)		(20,614	)
Miscellaneous- Net		(83	)		849			1,878			3,593
Income (Loss) Before Income Taxes		51,694			(317,078	)		207,259			(185,605	)
Provision for Income Taxes		15,612			(120,128	)		63,790			(78,036	)
Net Income (Loss)	$	36,082		$	(196,950	)	$	143,469		$	(107,569	)
Share Data:
Net Income (Loss) per Diluted Share	$	0.60		$	(3.29	)	$	2.36		$	(1.79	)
Average Diluted Shares Outstanding		60,485			59,884			60,694			60,008
Average Basic Shares Outstanding		59,811			59,884			59,884			60,008
Supplemental Data:
Cost of Sales - Operations	$	434,382		$	445,603		$	1,342,560		$	1,321,560
Asbestos Provision		—			390,150			—			390,150
Selling, General & Administrative		153,678			140,957			456,230			413,919
Depreciation and Amortization**		14,270			13,672			43,965			44,740
Stock Compensation Expense		3,462			3,797			10,447			11,173

* Operating profit for the first nine months of 2008 includes $4.4 million of recoveries related to environmental activities, and operating profit for the first nine months of 2007 includes a $7.6 million provision for a legal settlement.

** Amount included within cost of sales and selling, general & administrative costs.

CRANE CO.

Condensed Balance Sheets

(in thousands)

	September 30, 2008		December 31, 2007
ASSETS
Current Assets
Cash and Cash Equivalents	$	278,431	$	283,370
Accounts Receivable		359,418		345,176
Current Insurance Receivable - Asbestos		33,600		33,600
Inventories		368,530		327,719
Other Current Assets		64,289		47,757
Total Current Assets		1,104,268		1,037,622
Property, Plant and Equipment		293,606		289,683
Long-Term Insurance Receivable - Asbestos		276,449		306,557
Long-Term Deferred Tax Assets		187,189		220,370
Other Assets		233,557		256,510
Goodwill		770,052		766,550
Total Assets	$	2,865,121	$	2,877,292
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Notes Payable and Current Maturities of Long-Term Debt	$	1,022	$	548
Accounts Payable		195,787		177,978
Current Asbestos Liability		84,000		84,000
Accrued Liabilities		234,828		230,295
Income Taxes		2,073		731
Total Current Liabilities		517,710		493,552
Long-Term Debt		398,434		398,301
Deferred Tax Liability		32,014		31,880
Long-Term Asbestos Liability		877,754		942,776
Other Liabilities		103,550		117,586
Minority Interest		7,811		8,394
Shareholders’ Equity		927,848		884,803
Total Liabilities and Shareholders’ Equity	$	2,865,121	$	2,877,292

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2008			2007			2008			2007
Operating Activities:
Net income (loss)	$	36,082		$	(196,950	)	$	143,469		$	(107,569	)
Income from joint venture		—			(1,253	)		—			(3,798	)
Asbestos provision, net		—			390,150			—			390,150
(Gain) loss on divestitures		—			975			(932	)		975
Depreciation and amortization		14,270			13,672			43,965			44,740
Stock-based compensation expense		3,462			3,797			10,447			11,173
Deferred income taxes		10,774			(130,775	)		22,639			(140,243	)
Cash used for operating working capital		10,853			6,600			(35,435	)		(39,532	)
Other		(16,173	)		(2,758	)		(18,774	)		(16,889	)
Subtotal		59,268			83,458			165,379			139,007
Asbestos related payments, net of insurance recoveries		(18,301	)		(7,897	)		(34,915	)		7,311
Total provided by operating activities		40,967			75,561			130,464			146,318
Investing Activities:
Capital expenditures		(13,257	)		(11,581	)		(33,658	)		(33,412	)
Proceeds from disposition of capital assets		284			374			728			11,610
Proceeds from divestitures		—			2,005			2,106			2,005
Payment for acquisition, net of cash acquired		(27,877	)		(65,311	)		(28,009	)		(65,166	)
Total used for investing activities		(40,850	)		(74,513	)		(58,833	)		(84,963	)
Financing Activities:
Dividends paid		(11,965	)		(10,789	)		(33,521	)		(28,828	)
Reacquisition of shares on the open market		—			—			(40,000	)		(50,001	)
Stock options exercised - net of shares reacquired		(387	)		2,958			8,704			10,102
Excess tax benefit from stock-based compensation		488			1,954			1,388			4,081
Repayment of long-term debt		—			(211	)		—			(300	)
Net increase (decrease) in short-term debt		(2,631	)		24,100			411			15,492
Total used for financing activities		(14,495	)		18,012			(63,018	)		(49,454	)
Effect of exchange rate on cash and cash equivalents		(28,739	)		8,113			(13,552	)		11,740
(Decrease) increase in cash and cash equivalents		(43,117	)		27,173			(4,939	)		23,641
Cash and cash equivalents at beginning of period		321,548			135,075			283,370			138,607
Cash and cash equivalents at end of period	$	278,431		$	162,248		$	278,431		$	162,248

CRANE CO.

Order Backlog

(in thousands)

	September 30, 2008		June 30, 2008		December 31, 2007		September 30, 2007
Aerospace & Electronics	$	418,317	$	417,883	$	392,822	$	398,725
Engineered Materials		11,035		11,892		14,802		14,466
Merchandising Systems		25,676		35,708		34,093		30,825
Fluid Handling		285,988		297,937		242,591		266,920
Controls		37,816		41,633		35,273		42,217
Total Backlog	$	778,832	$	805,053	$	719,581	$	753,153

CRANE CO.

Non-GAAP Financial Measures

(in thousands, except for per share amounts)

	Three Months Ended September 30,						Nine Months Ended September 30,						Percent Change Three and Nine Months Ended September 30,
	2008			2007			2008			2007			2008		2007
INCOME ITEMS:
Net Sales	$	642,678		$	664,093		$	2,015,028		$	1,953,208		-3.2	%	3.2	%
Operating Profit (Loss)	$	54,618		$	(312,617	)	$	216,238		$	(172,421	)
Asbestos Provision - Pre-Tax (a)					390,150						390,150
Government Settlement - Pre-Tax (b)											7,600
Environmental Reimbursement - Pre-Tax (c)								(4,444	)
Operating Profit before Asbestos Provision, Government Settlement and Environmental Reimbursement	$	54,618		$	77,533		$	211,794		$	225,329		-29.6	%	-6.0	%
Percentage of Sales		8.5	%		11.7	%		10.5	%		11.5	%
Net Income (Loss)	$	36,082		$	(196,950	)	$	143,469		$	(107,569	)
Per Share	$	0.60		$	(3.29	)	$	2.36		$	(1.79	)
Asbestos Provision - Net of Tax (a)					250,000						250,000
Per Share				$	4.18					$	4.16
Government Settlement - Net of Tax (b)											5,396
Per Share										$	0.09
Environmental Reimbursement - Net of Tax (c)								(2,889	)
Per Share							$	(0.05	)
Net Income before Asbestos Provision, Government Settlement and Environmental Reimbursement	$	36,082		$	53,050		$	140,580		$	147,827		-32.0	%	-4.9	%
Per Share				$	0.89					$	2.46
Per Diluted Share	$	0.60		$	0.87		$	2.32		$	2.42
Average Diluted Shares Outstanding		60,485						60,694
In the three months and nine months ended September 30, 2007, Average Shares Outstanding excluding the effect of diluted stock options were used to compute the per share amounts since both periods were in a loss position. Had net income been reported for these periods, Average Shares Outstanding would have included the effect of diluted stock options when computing per share amounts (see chart below).
Average Basic Shares Outstanding					59,884						60,008
Effect of Diluted Stock Options					1,164						1,087
Average Shares Outstanding including the effect of Stock Options					61,048						61,095

When considering the effect of dilutive stock options on shares outstanding, Net Income before Asbestos Provision and Government Settlement is $0.87 per share and $2.42 for the three and nine months ended September 30, 2007, respectively.

(a) During the three months ended September 30, 2007, the Company recorded an Asbestos Provision.

(b) During the three months ended June 30, 2007, the Company recorded a settlement with the US Government.

(c) During the three months ended June 30, 2008, the Company recorded a $2.1 million reimbursement from the US Government and a $2.4 million reimbursement from a service provider, both related to environmental clean-up activities.

CRANE CO.

Non-GAAP Financial Measures

(in thousands, except for per share amounts)

	September 30, 2008			December 31, 2007
BALANCE SHEET ITEMS
Notes Payable and Current Maturities of Long-Term Debt	$	1,022		$	548
Long-Term Debt		398,434			398,301
Total Debt		399,456			398,849
Less: Cash and Cash Equivalents		(278,431	)		(283,370	)
Net Debt		121,025			115,479
Shareholders’ Equity		927,848			884,803
Net Capitalization	$	1,048,873		$	1,000,282
Percentage of Net Debt to Net Capitalization		11.5	%		11.5	%

	Three Months Ended September 30,						Nine Months Ended September 30,						Year Ended December 31,
	2008			2007			2008			2007			2008		2007
													(Estimated)
CASH FLOW ITEMS
Cash Provided from Operating Activities before Asbestos - Related Payments	$	59,268		$	83,458		$	165,379		$	139,007		230,000		$	243,031
Asbestos Related Payments, Net of Insurance Recoveries		(18,301	)		(7,897	)		(34,915	)		(24,189	)	(55,000	)		(41,698	)
Equitas Receipts		—			—			—			31,500		—			31,500
Cash Provided from Operating Activities		40,967			75,561			130,464			146,318		175,000			232,833
Less: Capital Expenditures		(13,257	)		(11,581	)		(33,658	)		(33,412	)	(45,000	)		(47,169	)
Free Cash Flow	$	27,710		$	63,980		$	96,806		$	112,906		130,000		$	185,664

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance. In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.